GPT and infection: For instance, a patient with early HCV and a high VL but a concomitant robust ALT elevation might still be within the period of enhanced treatment responsiveness, whereas a patient with the same duration of infection but a high VL and only a nominal concomitant ALT elevation might be too far into the transition to the chronic HCV phenotype to treat with short-course therapy.